DK1755583T3 - Anvendelse af neboglamin til behandling af skizofreni - Google Patents

Anvendelse af neboglamin til behandling af skizofreni

Info

Publication number
DK1755583T3
DK1755583T3 DK05747915.6T DK05747915T DK1755583T3 DK 1755583 T3 DK1755583 T3 DK 1755583T3 DK 05747915 T DK05747915 T DK 05747915T DK 1755583 T3 DK1755583 T3 DK 1755583T3
Authority
DK
Denmark
Prior art keywords
neboglamine
schizophrenia
treatment
dimethylcyclohexyl
racemate
Prior art date
Application number
DK05747915.6T
Other languages
English (en)
Inventor
Lucio Claudio Rovati
Francesco Makovec
Original Assignee
Rottapharm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rottapharm Spa filed Critical Rottapharm Spa
Application granted granted Critical
Publication of DK1755583T3 publication Critical patent/DK1755583T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK05747915.6T 2004-05-24 2005-05-23 Anvendelse af neboglamin til behandling af skizofreni DK1755583T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000343A ITTO20040343A1 (it) 2004-05-24 2004-05-24 Uso di neboglamine (cr2249) come neuropsicotico e neuroprotettivo
PCT/EP2005/052340 WO2005115373A1 (en) 2004-05-24 2005-05-23 Use of neboglamine (cr 2249) as an antipsychotic and neuroprotective

Publications (1)

Publication Number Publication Date
DK1755583T3 true DK1755583T3 (da) 2010-07-19

Family

ID=34968609

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05747915.6T DK1755583T3 (da) 2004-05-24 2005-05-23 Anvendelse af neboglamin til behandling af skizofreni

Country Status (13)

Country Link
US (1) US7737180B2 (da)
EP (1) EP1755583B1 (da)
JP (1) JP4898666B2 (da)
AT (1) ATE464042T1 (da)
AU (1) AU2005247114B2 (da)
CA (1) CA2567397C (da)
DE (1) DE602005020618D1 (da)
DK (1) DK1755583T3 (da)
ES (1) ES2340399T3 (da)
IT (1) ITTO20040343A1 (da)
PL (1) PL1755583T3 (da)
PT (1) PT1755583E (da)
WO (1) WO2005115373A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITTO20050691A1 (it) * 2005-10-04 2007-04-05 Rottapharm Spa Uso di neboglamine nella terapia delle tossicodipendenze

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1931927A1 (de) 1968-07-06 1970-01-15 Yamanouchi Pharma Co Ltd Neue Cyclohexylaminderivate
IT1264765B1 (it) * 1993-03-10 1996-10-04 Rotta Research Lab Derivati dell'acido glutammico ed acido aspartico, procedimento per la loro preparazione e loro uso come farmaci potenzianti la
AR037460A1 (es) * 2001-11-30 2004-11-10 Smithkline Beecham Plc Compuesto de hidroxietileno, composicion farmaceutica que lo comprende, uso del mismo para la fabricacion de un medicamento y procedimiento para su preparacion

Also Published As

Publication number Publication date
CA2567397C (en) 2013-03-12
AU2005247114A1 (en) 2005-12-08
PL1755583T3 (pl) 2010-09-30
JP2008500309A (ja) 2008-01-10
CA2567397A1 (en) 2005-12-08
JP4898666B2 (ja) 2012-03-21
US7737180B2 (en) 2010-06-15
ATE464042T1 (de) 2010-04-15
EP1755583A1 (en) 2007-02-28
AU2005247114B2 (en) 2010-06-03
EP1755583B1 (en) 2010-04-14
ES2340399T3 (es) 2010-06-02
US20070249715A1 (en) 2007-10-25
DE602005020618D1 (de) 2010-05-27
WO2005115373A1 (en) 2005-12-08
ITTO20040343A1 (it) 2004-08-24
PT1755583E (pt) 2010-05-07

Similar Documents

Publication Publication Date Title
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
BRPI0508051A (pt) derivados de heteroarilaminopirazol utilizáveis para o tratamento de diabetes
BRPI0416628A (pt) uso de compostos orgánicos
NO20050060L (no) Medikament for behandling av overaktiv blaere
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
DK1814534T3 (da) Derivater af 5-aminolevulinsyre til behandling af acne
IS8505A (is) (S)-2-N-própýlamínó-5-hýdroxýetralín sem D3-gerandefni
DK2023918T3 (da) Cyclosporiner til behandlingen og forebyggelse af okulære lidelser
WO2007112014A3 (en) New therapeutic combinations for the treatment of depression
SE0201544D0 (sv) Novel compounds and thier use
BRPI0616659A8 (pt) droga terapêutica antituberculose, medicamento, e, kit para o tratamento de tuberculose
DK1641454T3 (da) Pyrazolo[3,4-B]pyridin-6-oner som GSK-3-hæmmere
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
WO2002092072A3 (en) Drugs for the treatment of the alzheimer disease
EA200701856A1 (ru) Тетрагидропиридоазепин-8-оны и родственные соединения для лечения шизофрении
DK1614419T3 (da) Midler til forebyggelse/behandling af retinale nervesygdomme, indeholdende alkyletherderivater eller salte deraf
TW200640890A (en) Crystalline base of a pharmaceutical compound
DK1670903T3 (da) Behandling af neurodegenerative sygdomme
DK1853241T3 (da) Anvendelse af 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion ved behandling af Parkinson's sygdom
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
WO2008032222A3 (en) Treatment of vertigo with acetyl-l-leucine
WO2005119252A3 (en) Modulators of gpr35 for the treatment of metabolic-related disorders